{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:15:41Z","timestamp":1790720141663,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T00:00:00Z","timestamp":1541462400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12871-018-0626-1","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T16:16:07Z","timestamp":1541520967000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Hemodynamic instability during percutaneous ablation of extra-adrenal metastases of pheochromocytoma and paragangliomas: a case series"],"prefix":"10.1186","volume":"18","author":[{"given":"Atousa","family":"Deljou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob D.","family":"Kohlenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby N.","family":"Weingarten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Bancos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F.","family":"Young Jr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell R.","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0320-0230","authenticated-orcid":false,"given":"Juraj","family":"Sprung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,6]]},"reference":[{"issue":"12","key":"626_CR1","first-page":"802","volume":"58","author":"CM Beard","year":"1983","unstructured":"Beard CM, Sheps SG, Kurland LT, Carney JA, Lie JT. Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc. 1983;58(12):802\u20134.","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"626_CR2","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/MPA.0b013e3181ebb4f0","volume":"39","author":"H Chen","year":"2010","unstructured":"Chen H, Sippel RS, O'Dorisio MS, et al. The north American neuroendocrine tumor society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas. 2010;39(6):775\u201383.","journal-title":"Pancreas"},{"issue":"6","key":"626_CR3","doi-asserted-by":"publisher","first-page":"R253","DOI":"10.1530\/ERC-11-0170","volume":"18","author":"J Welander","year":"2011","unstructured":"Welander J, Soderkvist P, Gimm O. Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Endocr Relat Cancer. 2011;18(6):R253\u201376.","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"626_CR4","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4158\/EP161498.OR","volume":"23","author":"AE Espinosa De Ycaza","year":"2017","unstructured":"Espinosa De Ycaza AE, Welch TL, Ospina NS, et al. Image-guided thermal ablation of adrenal metastases: hemodynamic and endocrine outcomes. Endocr Pract. 2017;23(2):132\u201340.","journal-title":"Endocr Pract"},{"issue":"2","key":"626_CR5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s00270-016-1487-y","volume":"40","author":"AN Kurup","year":"2017","unstructured":"Kurup AN, Schmit GD, Morris JM, et al. Avoiding complications in bone and soft tissue ablation. Cardiovasc Intervent Radiol. 2017;40(2):166\u201376.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"6","key":"626_CR6","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.jvir.2012.02.013","volume":"23","author":"HJ Bang","year":"2012","unstructured":"Bang HJ, Littrup PJ, Currier BP, et al. Percutaneous cryoablation of metastatic lesions from non-small-cell lung carcinoma: initial survival, local control, and cost observations. J Vasc Interv Radiol. 2012;23(6):761\u20139.","journal-title":"J Vasc Interv Radiol"},{"issue":"6","key":"626_CR7","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jvir.2012.03.002","volume":"23","author":"HJ Bang","year":"2012","unstructured":"Bang HJ, Littrup PJ, Goodrich DJ, et al. Percutaneous cryoablation of metastatic renal cell carcinoma for local tumor control: feasibility, outcomes, and estimated cost-effectiveness for palliation. J Vasc Interv Radiol. 2012;23(6):770\u20137.","journal-title":"J Vasc Interv Radiol"},{"issue":"4 Part 1","key":"626_CR8","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1161\/01.CIR.14.4.622","volume":"14","author":"WF Kvale","year":"1956","unstructured":"Kvale WF, Manger WM, Priestley JT, Roth GM. Pheochromocytoma. Circulation. 1956;14(4 Part 1):622\u201330.","journal-title":"Circulation"},{"issue":"11","key":"626_CR9","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1210\/jc.2007-1720","volume":"92","author":"K Pacak","year":"2007","unstructured":"Pacak K. Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab. 2007;92(11):4069\u201379.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"626_CR10","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1007\/s00268-013-2325-x","volume":"38","author":"R Agrawal","year":"2014","unstructured":"Agrawal R, Mishra SK, Bhatia E, et al. Prospective study to compare peri-operative hemodynamic alterations following preparation for pheochromocytoma surgery by phenoxybenzamine or prazosin. World J Surg. 2014;38(3):716\u201323.","journal-title":"World J Surg"},{"issue":"9","key":"626_CR11","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s00268-005-7839-4","volume":"29","author":"A Agarwal","year":"2005","unstructured":"Agarwal A, Gupta S, Mishra AK, Singh N, Mishra SK. Normotensive pheochromocytoma: institutional experience. World J Surg. 2005;29(9):1185\u20138.","journal-title":"World J Surg"},{"issue":"1","key":"626_CR12","first-page":"44","volume":"28","author":"SJ Shen","year":"2005","unstructured":"Shen SJ, Cheng HM, Chiu AW, Chou CW, Chen JY. Perioperative hypertensive crisis in clinically silent pheochromocytomas: report of four cases. Chang Gung Med J. 2005;28(1):44\u201350.","journal-title":"Chang Gung Med J"},{"issue":"2","key":"626_CR13","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.urology.2010.03.032","volume":"76","author":"TN Weingarten","year":"2010","unstructured":"Weingarten TN, Cata JP, O'Hara JF, et al. Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma. Urology. 2010;76(2):508 e6\u201311.","journal-title":"Urology"},{"issue":"3","key":"626_CR14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/01.RVI.0000197370.83569.33","volume":"17","author":"TD Atwell","year":"2006","unstructured":"Atwell TD, Wass CT, Charboneau JW, Callstrom MR, Farrell MA, Sengupta S. Malignant hypertension during cryoablation of an adrenal gland tumor. J Vasc Interv Radiol. 2006;17(3):573\u20135.","journal-title":"J Vasc Interv Radiol"},{"key":"626_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijsu.2017.08.026","volume":"46","author":"JJ Butz","year":"2017","unstructured":"Butz JJ, Weingarten TN, Cavalcante AN, et al. Perioperative hemodynamics and outcomes of patients on metyrosine undergoing resection of pheochromocytoma or paraganglioma. Int J Surg. 2017;46:1\u20136.","journal-title":"Int J Surg"},{"issue":"6","key":"626_CR16","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.surg.2017.08.002","volume":"162","author":"JJ Butz","year":"2017","unstructured":"Butz JJ, Yan Q, McKenzie TJ, et al. Perioperative outcomes of syndromic paraganglioma and pheochromocytoma resection in patients with von Hippel-Lindau disease, multiple endocrine neoplasia type 2, or neurofibromatosis type 1. Surgery. 2017;162(6):1259\u201369.","journal-title":"Surgery"},{"issue":"9","key":"626_CR17","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.jvir.2011.06.016","volume":"22","author":"JF McBride","year":"2011","unstructured":"McBride JF, Atwell TD, Charboneau WJ, Young WF Jr, Wass TC, Callstrom MR. Minimally invasive treatment of metastatic pheochromocytoma and paraganglioma: efficacy and safety of radiofrequency ablation and cryoablation therapy. J Vasc Interv Radiol. 2011;22(9):1263\u201370.","journal-title":"J Vasc Interv Radiol"},{"key":"626_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1196\/annals.1353.044","volume":"1073","author":"M Mannelli","year":"2006","unstructured":"Mannelli M. Management and treatment of pheochromocytomas and paragangliomas. Ann N Y Acad Sci. 2006;1073:405\u201316.","journal-title":"Ann N Y Acad Sci"},{"key":"626_CR19","volume-title":"Treatment of pheochromocytoma in adults","author":"WF Young Jr","year":"2017","unstructured":"Young WF, Jr, Kebebew E. Treatment of pheochromocytoma in adults 2017 [cited 2018 Feb 15. Available from URL; \n                    https:\/\/www.uptodate.com\/contents\/treatment-of-pheochromocytoma-in-adults\n                    \n                  ."},{"issue":"11","key":"626_CR20","first-page":"42","volume":"28","author":"V Herasevich","year":"2011","unstructured":"Herasevich V, Kor DJ, Li M, Pickering BW. ICU data mart: a non-iT approach. A team of clinicians, researchers and informatics personnel at the Mayo Clinic have taken a homegrown approach to building an ICU data mart. Healthc Inform. 2011;28(11):42 4\u20135.","journal-title":"Healthc Inform"},{"issue":"4","key":"626_CR21","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1530\/eje.1.01987","volume":"153","author":"TT Huynh","year":"2005","unstructured":"Huynh TT, Pacak K, Brouwers FM, et al. Different expression of catecholamine transporters in phaeochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2. Eur J Endocrinol. 2005;153(4):551\u201363.","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"626_CR22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1590\/S1677-55382005000400002","volume":"31","author":"MF Rocha","year":"2005","unstructured":"Rocha MF, Tauzin-Fin P, Vasconcelos PL, Ballanger P. Assessment of serum catecholamine concentrations in patients with pheochromocytoma undergoing videolaparoscopic adrenalectomy. Int Braz J Urol. 2005;31(4):299\u2013307.","journal-title":"Int Braz J Urol"},{"issue":"1","key":"626_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1590\/S1677-55382011000100005","volume":"37","author":"G Song","year":"2011","unstructured":"Song G, Joe BN, Yeh BM, Meng MV, Westphalen AC, Coakley FV. Risk of catecholamine crisis in patients undergoing resection of unsuspected pheochromocytoma. Int Braz J Urol. 2011;37(1):35\u201340 discussion \u22121.","journal-title":"Int Braz J Urol"},{"issue":"6","key":"626_CR24","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1055\/s-2007-996507","volume":"30","author":"J Schuttler","year":"1995","unstructured":"Schuttler J, Westhofen P, Kania U, Ihmsen H, Kammerecker S, Hirner A. Quantitative assessment of catecholamine secretion as a rational principle of anesthesia management in pheochromocytoma surgery. Anasthesiol Intensivmed Notfallmed Schmerzther. 1995;30(6):341\u20139.","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"issue":"6","key":"626_CR25","first-page":"1064","volume":"104","author":"KA Newell","year":"1988","unstructured":"Newell KA, Prinz RA, Brooks MH, Glisson SN, Barbato AL, Freeark RJ. Plasma catecholamine changes during excision of pheochromocytoma. Surgery. 1988;104(6):1064\u201373.","journal-title":"Surgery"},{"issue":"4","key":"626_CR26","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s00270-010-0078-6","volume":"34","author":"K Yamakado","year":"2011","unstructured":"Yamakado K, Takaki H, Uchida K, Nakatsuka A, Shiraishi T, Takeda K. Adrenal radiofrequency ablation in swine: change in blood pressure and histopathologic analysis. Cardiovasc Intervent Radiol. 2011;34(4):839\u201344.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"3","key":"626_CR27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jvir.2015.11.034","volume":"27","author":"FJ Fintelmann","year":"2016","unstructured":"Fintelmann FJ, Tuncali K, Puchner S, et al. Catecholamine surge during image-guided ablation of adrenal gland metastases: predictors, consequences, and recommendations for management. J Vasc Interv Radiol. 2016;27(3):395\u2013402.","journal-title":"J Vasc Interv Radiol"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-018-0626-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12871-018-0626-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-018-0626-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T19:06:06Z","timestamp":1572980766000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-018-0626-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,6]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["626"],"URL":"https:\/\/doi.org\/10.1186\/s12871-018-0626-1","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,6]]},"assertion":[{"value":"17 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Study was approved by the Mayo Clinic Institutional Review Board in November 2014 (No. 13\u2013004137), with the last modification approved in November 2017 (No. 14\u2013008336); patients who declined authorization for research use of their medical records were excluded.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We, the authors, declare that we have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"158"}}